Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T9216 |
MLT-943
MLT943 |
MALT | Immunology/Inflammation |
ML-943 是选择性的、口服活性的MALT1 protease 抑制剂。它可抑制 PBMC 或全血中 IL-2 的分泌,PBMC 中抑制的IC50值为 0.07~0.09 μM,全血中抑制的IC50值为 0.6~0.8 μM)。它具有抗炎作用,可用于研究 FcgR 介导的炎症。 | |||
T78967 |
Anti-inflammatory agent 40
|
Parasite | Microbiology/Virology |
Anti-inflammatory agent 40 是潜在的口服抗疟疾(anti-malarial)与抗炎(Anti-inflammatory)化合物,能抑制卡拉胶诱导的足跖肿胀。 | |||
T68393 | SNX-7081 | ||
NX-7081 is a novel small molecule inhibitor of Hsp90, which blocks components of inflammation, including cytokine production, protein kinase activity, and angiogenic signaling. SNX-7081 showed strong binding affinity to Hsp90 and expected induction of Hsp70. NF-kappaB nuclear translocation was blocked by SNX-7081 at nanomolar concentrations, and cytokine production was potently inhibited. Growth factor activation of ERK and JNK signaling was significantly reduced by SNX-7081. NO production was a... | |||
T69451 | R-130823 | ||
R-130823 is a ighly selective inhibition against mitogen-activated protein kinase p38alpha (IC50=22 nM). The release of tumor necrosis factor-alpha, interleukin-1beta, -6 and -8 was inhibited in lipopolysaccharide-stimulated human blood pretreated by R-130823 , with IC50 values of 0.089, 0.066, 0.95 and 0.16 microM, respectively. R-130823 reduced the established hind paw swelling in rat adjuvant-induced arthritis, while methotrexate showed no suppression. In the same model, R-130823 ameliorated ... |